Literature DB >> 12502998

Intrathecal lidocaine reverses tactile allodynia caused by nerve injuries and potentiates the antiallodynic effect of the COX inhibitor ketorolac.

Weiya Ma1, Wei Du, James C Eisenach.   

Abstract

BACKGROUND: Systemic lidocaine and other local anesthetics reduce hypersensitivity states induced by both acute inflammation and peripheral nerve injury in animals and produce analgesia in some patients with chronic pain. The mechanisms underlying the antiallodynic effect of systemic lidocaine are unclear, although most focus is on peripheral mechanisms. Central mechanisms, particularly at the spinal dorsal horn level, are less known. In this study, the authors aimed to determine whether intrathecal lidocaine has an antiallodynic effect on established mechanical allodynia in two well-characterized neuropathic pain rat models: partial sciatic nerve ligation (PSNL) and spinal nerve ligation (SNL).
METHODS: Lidocaine (100-300 micro g) was intrathecally injected in PSNL and SNL rats. The withdrawal threshold of both hind paws in response to mechanical stimulation was measured using a series of calibrated von Frey filaments.
RESULTS: This single injection reduced ongoing tactile allodynia in PSNL and SNL rats. The antiallodynic effect of intrathecal lidocaine lasted longer in PSNL (> 3 days) than in SNL rats (< 3 days). Intraperitoneal lidocaine (300 micro g) had no effect on tactile allodynia in PSNL rats. In SNL rats, prior intrathecal lidocaine (200 and 300 micro g) potentiated the antiallodynic effect of intrathecal ketorolac, a nonselective cyclooxygenase inhibitor. Intrathecal ketorolac alone had no antiallodynic effect on SNL rats. However, prior intrathecal lidocaine (100 micro g) failed to potentiate the antiallodynic effect of intrathecal ketorolac.
CONCLUSION: The authors' data suggest that intrathecal lidocaine possibly suppressed the hyperexcitability of the dorsal horn neurons and likely interacted with eicosanoid systems in the spinal dorsal horn.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12502998     DOI: 10.1097/00000542-200301000-00031

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  5 in total

1.  Lidocaine prevents referred hyperalgesia associated with cystitis.

Authors:  Simone D Guerios; Zun-Yi Wang; Kyle Boldon; Wade Bushman; Dale E Bjorling
Journal:  Neurourol Urodyn       Date:  2009       Impact factor: 2.696

Review 2.  Behavioral models of pain states evoked by physical injury to the peripheral nerve.

Authors:  Linda S Sorkin; Tony L Yaksh
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

3.  Intrathecal lidocaine pretreatment attenuates immediate neuropathic pain by modulating Nav1.3 expression and decreasing spinal microglial activation.

Authors:  Kuang-I Cheng; Chung-Sheng Lai; Fu-Yuan Wang; Hung-Chen Wang; Lin-Li Chang; Shung-Tai Ho; Hung-Pei Tsai; Aij-Li Kwan
Journal:  BMC Neurol       Date:  2011-06-16       Impact factor: 2.474

4.  8-O-Acetyl Shanzhiside Methylester From Lamiophlomis Rotata Reduces Neuropathic Pain by Inhibiting the ERK/TNF-α Pathway in Spinal Astrocytes.

Authors:  Wei Zhang; Yang Bai; Yu Qiao; Jian Wang; Meng-Ying Li; Jing-Wen Wang; Na Jia; Tao Chen; Yun-Qing Li; Ai-Dong Wen
Journal:  Front Cell Neurosci       Date:  2018-03-08       Impact factor: 5.505

5.  Intrathecal lamotrigine attenuates mechanical allodynia and suppresses microglial and astrocytic activation in a rat model of spinal nerve ligation.

Authors:  Yun-Sik Choi; In-Gu Jun; Sung-Hoon Kim; Jong-Yeon Park
Journal:  Yonsei Med J       Date:  2013-03-01       Impact factor: 2.759

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.